| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/01/2009 | US20090005413 Novel Salt of Montelukast |
| 12/31/2008 | WO2009002955A1 Process for the preparation of (2r)-2-[4-(7-bromo-2-quinolyloxy)phenoxy]propanoic acid |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001374A2 Preparation of ethyl-3'-[((7-chloro-2-quinolinyl)ethenyl)phenyl]-3-oxopropanoate, a key intermediate for montelukast sodium |
| 12/31/2008 | WO2009000085A1 Quinoline and quinazoline derivatives useful as modulators of gated ion channels |
| 12/31/2008 | WO2008141012A3 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 12/31/2008 | WO2008136693A3 Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid |
| 12/31/2008 | WO2008132139A3 New heterocyclic derivatives useful for the treatment of cns disorders |
| 12/31/2008 | WO2008011476A3 Compositions and methods for modulating sirtuin activity |
| 12/31/2008 | EP2008992A1 Aromatic amine derivative and organic electroluminescent device using the same |
| 12/31/2008 | EP2007728A1 A process for preparing tetrahydroquinoline derivatives |
| 12/31/2008 | EP2007727A1 Quinoline derivatives and their use as pesticides |
| 12/31/2008 | EP2007707A1 Compounds which modulate the cb2 receptor |
| 12/31/2008 | CN101336233A Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| 12/31/2008 | CN101333189A Aripiprazole crystal form suitable for pharmaceutical use, preparation method and pharmaceutical compositions |
| 12/31/2008 | CN101333188A Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/30/2008 | US7470928 Red phosphorescence compounds |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470788 Antitumor agents |
| 12/30/2008 | US7470787 Kinase inhibitors; anticarcinogenic agents; obesity, glaucoma; N-(4-(3-(isoquinolin-6-ylamino)-3-oxopropyl)phenyl)-4-methoxybenzamide |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 12/30/2008 | US7470706 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
| 12/25/2008 | US20080319011 Protein tyrosine kinase enzyme inhibitors |
| 12/25/2008 | US20080319007 Deuterium-enriched montelukast |
| 12/25/2008 | US20080318959 using 3-amino-5-ethyl-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide |
| 12/25/2008 | US20080318958 New utilities of tricyclic compounds |
| 12/25/2008 | US20080318957 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
| 12/25/2008 | US20080317662 Molten Salts, Method of Their Production and Process for Generating Hydrogen Peroxide |
| 12/24/2008 | WO2008157658A1 Deuterium-enriched montelukast |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008155588A1 Sulfonyl-quinoline derivatives |
| 12/24/2008 | WO2008155468A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155441A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008082715A3 Sox-based kinase sensor |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 12/24/2008 | EP2004609A2 Process for preparing a leukotriene antagonist |
| 12/24/2008 | EP2004608A1 An improved process for the manufacture of montelukast sodium |
| 12/24/2008 | EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
| 12/24/2008 | EP2004189A2 Thiazolidinedione derivatives as pi3 kinase inhibitors |
| 12/24/2008 | EP2004166A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
| 12/24/2008 | EP1660483B1 8-(1-piperazinyl)-quinoline derivatives and their use in the treatment of cns disorders |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100445267C Process for preparing 4-(4-fluoro-phenyl)-3- hydroxymethyl-2- cyclopropyl-quinoline |
| 12/24/2008 | CA2691227A1 Activators and therapeutic applications thereof |
| 12/24/2008 | CA2690079A1 Sulfonyl-quinoline derivatives |
| 12/23/2008 | US7468378 Substituted quinoline compounds |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/18/2008 | WO2008154484A1 Ire-1a inhibitors |
| 12/18/2008 | WO2008154382A1 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 12/18/2008 | US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 12/18/2008 | US20080312292 Antipruritics |
| 12/18/2008 | US20080312278 Hydroxyquinoline Derivatives |
| 12/18/2008 | US20080312277 Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders |
| 12/18/2008 | US20080312274 Quinoline Derivatives as Neurokinin Receptor Antagonists |
| 12/18/2008 | US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity |
| 12/18/2008 | US20080312270 Compounds and methods useful for treating asthma and allergic inflammation |
| 12/18/2008 | US20080312262 Such as 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)oxy]ethyl}carbamate; sleep disorders |
| 12/18/2008 | US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080312233 Therapeutic Morpholino-Substituted Compounds |
| 12/18/2008 | US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 12/18/2008 | US20080311427 Organometallic complex, method of preparing the same and organic light emitting device comprising the same |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/18/2008 | US20080308770 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors |
| 12/18/2008 | CA2726734A1 Hdac inhibitor ms-275 and aromatase inhibitors for the treatment of cancer |
| 12/18/2008 | CA2690913A1 Ire-1alpha inhibitors |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases |
| 12/17/2008 | EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/17/2008 | EP1773763B1 Lysine based compounds |
| 12/17/2008 | EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 12/17/2008 | CN101323590A Novel synthetic method of aripiprazole and intermediate thereof |
| 12/17/2008 | CN101323589A Preparation of novel compound and montelukast sodium |
| 12/17/2008 | CN101323580A Synthetic methods of chiral aryloxy propanol amine compounds and salts thereof |
| 12/16/2008 | US7465799 Methods and compositions for selectin inhibition |
| 12/16/2008 | US7465798 Methods and compositions for selectin inhibition |
| 12/16/2008 | US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders |
| 12/16/2008 | CA2302937C Method for producing (hetero)aromatic hydroxylamines |
| 12/11/2008 | WO2008150029A1 Quinolone compound and pharmaceutical composition |
| 12/11/2008 | WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 12/11/2008 | WO2008149168A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 12/11/2008 | WO2008148468A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 12/11/2008 | WO2008008374A3 Ccr2 inhibitors and methods of use thereof |
| 12/11/2008 | US20080306270 Process for the Preparation of a Leukotriene Antagonist and Intermediates Thereof |
| 12/11/2008 | US20080306162 Treatment of Inflammatory Disorders and Pain |
| 12/11/2008 | US20080306136 Substituted Ureas and Carbamates |
| 12/11/2008 | US20080306110 Alkylnitrile Quinolines as Nk-3 Receptor Ligands |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306084 Substituted Amide Compounds |
| 12/11/2008 | US20080306053 Modulation of chemosensory receptors and ligands associated therewith |
| 12/11/2008 | US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use |
| 12/11/2008 | CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 12/11/2008 | CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
| 12/11/2008 | CA2689612A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 12/11/2008 | CA2688448A1 Quinolone compound and pharmaceutical composition |
| 12/10/2008 | EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |